Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells*

We have recently identified two different pathways of CD95-mediated apoptosis (Scaffidi, C., Fulda, S., Srinivasan, A., Feng, L., Friesen, C., Tomaselli, K. J., Debatin, K.-M., Krammer, P. H., and Peter, M. E. (1998) EMBO J. 17, 1675–1687). CD95-mediated apoptosis in type I cells is initiated by large amounts of active caspase-8 formed at the death-inducing signaling complex (DISC) followed by direct cleavage of caspase-3. In contrast, in type II cells very little DISC and small amounts of active caspase-8 sufficient to induce the apoptogenic activity of mitochondria are formed causing a profound activation of both caspase-8 and caspase-3. Only in type II cells can apoptosis be blocked by overexpressed Bcl-2 or Bcl-xL. We now show that a number of apoptosis-inhibiting or -inducing stimuli only affect apoptosis in type II cells, indicating that they act on the mitochondrial branch of the CD95 pathway. These stimuli include the activation of protein kinase C, which inhibits CD95-mediated apoptosis resulting in a delayed cleavage of BID, and the induction of apoptosis by the ceramide analog C2-ceramide. In addition, we have identified the CD95 high expressing cell line BoeR as a CD95 apoptosis-resistant type II cell that can be sensitized by treatment with cycloheximide without affecting formation of the DISC. This also places the effects of cycloheximide in the mitochondrial branch of the type II CD95 pathway. In contrast, c-FLIP was found to block CD95-mediated apoptosis in both type I and type II cells, because it acts directly at the DISC of both types of cells.

[1]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[2]  D. Green,et al.  Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. , 1998, Blood.

[3]  J. Inokuchi,et al.  Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide , 1998, FEBS letters.

[4]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[5]  M. Peter,et al.  Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid* , 1998, The Journal of Biological Chemistry.

[6]  E. Clementi,et al.  Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Honglin Zhou,et al.  Regulation of Insulin-Stimulated Glucose Transporter GLUT4 Translocation and Akt Kinase Activity by Ceramide , 1998, Molecular and Cellular Biology.

[8]  C. Franceschi,et al.  JC‐1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis , 1997, FEBS letters.

[9]  M. Kitagawa,et al.  Transcriptional Activation of the cdc2 Gene Is Associated with Fas-induced Apoptosis of Human Hematopoietic Cells* , 1996, The Journal of Biological Chemistry.

[10]  P. Krammer,et al.  Activation interferes with the APO-1 pathway in mature human T cells. , 1993, International immunology.

[11]  T. Tsukahara,et al.  Wortmannin enhances activation of CPP32 (Caspase-3) induced by TNF or anti-Fas , 1998, Cell Death and Differentiation.

[12]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[13]  T. Billiar,et al.  Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[14]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[15]  R. Kofler,et al.  Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl‐2, but not by CrmA , 1997, FEBS letters.

[16]  S. Korsmeyer,et al.  Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.

[17]  W. V. van Blitterswijk,et al.  CD95 (Fas/APO-1) Induces Ceramide Formation and Apoptosis in the Absence of a Functional Acid Sphingomyelinase* , 1998, The Journal of Biological Chemistry.

[18]  R. Testi,et al.  Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.

[19]  J C Reed,et al.  Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.

[20]  L. Drew,et al.  Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells. , 1998, International immunology.

[21]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[22]  E. Kishida,et al.  Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. , 1998, Biochimica et biophysica acta.

[23]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[24]  M. Peter,et al.  Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. , 1995, Cell death and differentiation.

[25]  D. Cantrell,et al.  Protection of CD95‐mediated apoptosis by activation of phosphatidylinositide 3‐kinase and protein kinase B , 1998, European journal of immunology.

[26]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[27]  P. Möller,et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.

[28]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[29]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[30]  Javier Naval,et al.  Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[31]  R. Aebersold,et al.  Fas-induced apoptosis of T cells occurs independently of ceramide generation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Matthias Mann,et al.  FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) , 1997, The EMBO journal.

[33]  I. Herr,et al.  Activation of CD95 (APO‐1/Fas) signaling by ceramide mediates cancer therapy‐induced apoptosis , 1997, The EMBO journal.

[34]  S. Orrenius,et al.  Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. , 1998, Journal of immunology.

[35]  J. Jaffrezou,et al.  Positive feedback control of neutral sphingomyelinase activity by ceramide , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  H. Umehara,et al.  Requirement of AP-1 for Ceramide-induced Apoptosis in Human Leukemia HL-60 Cells (*) , 1995, The Journal of Biological Chemistry.

[37]  J. Tschopp,et al.  FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. , 1998, Journal of immunology.

[38]  W. V. van Blitterswijk,et al.  The role of ceramide in apoptosis , 2000 .

[39]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[40]  D. Green,et al.  Inhibition of ceramide-induced apoptosis by Bcl-2. , 1995, Cell death and differentiation.

[41]  Javier Naval,et al.  Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathway , 1998, Cell Death and Differentiation.

[42]  C. Hoppel,et al.  Direct Inhibition of Mitochondrial Respiratory Chain Complex III by Cell-permeable Ceramide* , 1997, The Journal of Biological Chemistry.

[43]  S. Spiegel,et al.  Sphingosine 1-Phosphate Inhibits Activation of Caspases that Cleave Poly(ADP-ribose) Polymerase and Lamins during Fas- and Ceramide-mediated Apoptosis in Jurkat T Lymphocytes* , 1998, The Journal of Biological Chemistry.

[44]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[45]  S. Jee,et al.  Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells. , 1997, The Biochemical journal.

[46]  Seamus J. Martin,et al.  Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.

[47]  I. Stamenkovic,et al.  Superoxide anion is a natural inhibitor of FAS‐mediated cell death. , 1996, The EMBO journal.

[48]  A. Colell,et al.  Direct Effect of Ceramide on the Mitochondrial Electron Transport Chain Leads to Generation of Reactive Oxygen Species , 1997, The Journal of Biological Chemistry.

[49]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[50]  S. Spiegel,et al.  Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.

[51]  Y. Hannun,et al.  Cytokine Response Modifier A (CrmA) Inhibits Ceramide Formation in Response to Tumor Necrosis Factor (TNF)-α: CrmA and Bcl-2 Target Distinct Components in the Apoptotic Pathway , 1997, The Journal of experimental medicine.

[52]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[53]  J. Heeney,et al.  Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. , 1994, AIDS research and human retroviruses.

[54]  E. Bártová,et al.  Apoptotic damage of DNA in human leukaemic HL-60 cells treated with C2-ceramide was detected after G1 blockade of the cell cycle. , 1997, Physiological research.

[55]  A. Zeiher,et al.  Nitric oxide inhibits APO-1/Fas-mediated cell death. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[56]  S. Moncada,et al.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide , 1994, FEBS letters.

[57]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[58]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[59]  S. Korsmeyer,et al.  Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors* , 1996, The Journal of Biological Chemistry.

[60]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[61]  N. Miyasaka,et al.  Ceramide induces apoptosis via CPP32 activation , 1996, FEBS letters.

[62]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[63]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[64]  W. Fiers,et al.  Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways , 1998, The Journal of experimental medicine.

[65]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[66]  Honglin Zhou,et al.  Inhibition of Akt Kinase by Cell-permeable Ceramide and Its Implications for Ceramide-induced Apoptosis* , 1998, The Journal of Biological Chemistry.

[67]  M. Peter,et al.  Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. , 1998, Current opinion in immunology.

[68]  M. Peter,et al.  The death receptors. , 1999, Results and problems in cell differentiation.